Karina R. Bondarenko

Karina R. Bondarenko

Auto-generated profile, based on publicly available information

Karina R. Bondarenko

Department of Obstetrics and Gynecology Therapeutic Faculty Pirogov Russian National Research Medical University Moscow Russia

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2018 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
DDDobrokhotova Yu.E. Dobrokhotova
Dobrokhotova Yu.E. Dobrokhotova
BBBondarenko K.R. Bondarenko
Bondarenko K.R. Bondarenko
GGGushchin A.E. Gushchin
Gushchin A.E. Gushchin
RRRumyantseva T.A. Rumyantseva
Rumyantseva T.A. Rumyantseva
DDDolgova T.V. Dolgova
Dolgova T.V. Dolgova
2R2 Central Research Institute of Epidemiology of Rospotrebnadzor
2 Central Research Institute of Epidemiology of Rospotrebnadzor

3 January 2017 in Journal of Endometriosis and Pelvic Pain Disorders
Verified
Journal Article
Open access
JDJulia E. Dobrokhotova
Julia E. Dobrokhotova
IIIrina J. Ilyina
Irina J. Ilyina
IGIgor I. Grishin
Igor I. Grishin
DIDjamilya M. Ibragimova
Djamilya M. Ibragimova
DKDonna M. Kalimatova
Donna M. Kalimatova
VIVera J. Ilchenko
Vera J. Ilchenko
Background: The aim of the study was to evaluate the efficacy and safety of postoperative dienogest treatment in endometriosis patients. Materials and methods: A total of 53 patients suffering from endometriosis were enrolled. All participants underwent laparoscopic operative treatment. Afterwards, all patients were divided into 2 groups: Group 1 (control group) and Group 2 (receiving dienogest 2 mg/day after surgery). Comparative analysis was performed evaluating patients’ condition and complaints in the postoperative period, the disease dynamics at 3 and 6 months after the surgery, pain assessment (visual analogue scale) and severity of metrorrhagia in both groups. Results: Postoperative dienogest treatment reduces the severity of symptoms and improves treatment outcomes in endometriosis patients, leading to the improvement of the quality of life in these patients. Conclusions: Dienogest (2 mg/day) is a highly effective drug for postoperative treatment of patients with endometriosis. Dienogest (2 mg/day) significantly decreases the severity of pelvic pain and metrorrhagia after surgery. The medication is safe and side effects are rare.

1 January 2020 in Russian Journal of Woman and Child Health
Verified
Journal Article
Closed access
KBK.R. Bondarenko
K.R. Bondarenko
PKP.A. Kuznetsov
P.A. Kuznetsov
LDL.S. Dzhokhadze
L.S. Dzhokhadze
VLV.V. Lyan
V.V. Lyan
AKA.V. Kriger
A.V. Kriger
M2Moscow City Clinical Hospital No. 24
Moscow City Clinical Hospital No. 24
Антропометрический скрининг массы и длины тела новорожденного. Многоплодная беременности четко не. Двойня.

1 January 2016 in Voprosy Ginekologii, Akušerstva i Perinatologii
Verified
Journal Article
Closed access
LOL.A. Ozolinya
L.A. Ozolinya
ILI.A. Lapina
I.A. Lapina
KBK.R. Bondarenko
K.R. Bondarenko

6 February 2020 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
KBKarina R. Bondarenko
Karina R. Bondarenko
YDYulia E. Dobrokhotova
Yulia E. Dobrokhotova
TRTatiana A. Rumyantseva
Tatiana A. Rumyantseva
NNNailya I. Nasyrova
Nailya I. Nasyrova
Extraintestinal symptoms of Crohn's disease may occur in the eye, the urinary system, on the skin, or subcutaneous fat. We report the case of a 7‐year diagnostic search of isolated vulvar Crohn's disease in a 47‐year‐old woman. The disease is characterized by gradual formation of pronounced bilateral asymmetric labial hypertrophy.

30 May 2022 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
BBBondarenko K.R. Bondarenko
Bondarenko K.R. Bondarenko
KKKazantseva V.D. Kazantseva
Kazantseva V.D. Kazantseva
DYDobrokhotova Yu.E. Dobrokhotova Yu
Dobrokhotova Yu.E. Dobrokhotova Yu